从“血水同治”论治甲状腺相关性眼病

Treatment of thyroid-associated ophthalmopathy from“treating both blood and water”

甲状腺相关性眼病(TAO)是一种自身免疫性疾病,中医学将其归入“鹘眼凝睛”范畴,认为其发生与痰湿阻滞、血脉瘀滞密切相关。活血利水法是彭清华教授治疗眼底疾病的常用治法,笔者发现其法在治疗眼眶疾病上同样疗效甚佳。血水在生理上同源,在病理上共病,其病理产物痰湿与血瘀恰与TAO的致病因素相拟合。故基于“血水同治”理论,分阶段探讨眼病“痰瘀互结”的病机特点,并提出“调理气机”对治疗痰瘀互结型TAO的重要性,为其辨证论治提供新思路、新方向。

Thyroid-associated ophthalmopathy(TAO)is an autoimmune disease,which is classified as“eye-catching”in traditional Chinese medicine,and it is considered that its occurrence is closely related to phlegm-dampness block and blood stasis.Ophthalmology method of promoting blood circulation and promoting diuresis is a commonly used treatment for fundus diseases by professor Peng Qinghua.The author found that it is equally effective in treating orbital diseases.Blood and water are physiologically homologous and pathologically co-morbid,and its pathological products,phlegm-dampness and blood stasis,are just consistent with the pathogenic factors of TAO.Therefore,based on the theory of“treating both blood and water”,this paper discusses the pathogenesis characteristics of“phlegm and blood stasis”of eye diseases in stages,and puts forward the importance of“regulating Qi-flow”in treating TAO,providing new ideas and new directions for its syndrome differentiation and treatment.